Table III.
E-cadherin, ICAM-1, and MHC-I molecule expression on NSCLC and SCLC cell lines
| E-cadherin | ICAM-1 | MHC-I | |
|---|---|---|---|
| NSCLC cell lines | |||
| LCC | |||
| IGR-Heu (patient 1) | 100%a (137) | 12% (14) | 100% (60) |
| IGR-B2 (patient 2) | 45% (146) | 98% (1619) | 100% (743) |
| LCC-M4 | 95% (53) | ND | 99% (43) |
| H1155 | 1% | 27% (35) | 100% (855) |
| H460 | 1% | 88% (159) | 100% (412) |
| ADC | |||
| ADC-Coco (patient 3) | 1% | 0% | 1% |
| IGR-Pub (patient 4) | 20% (31) | 99% (486) | 100% (393) |
| ADC-Tor | 3% | 43% (46) | 100% (807) |
| ADC-Let | 3% | ND | 100% (499) |
| A549 | 1% | ND | 7% (36) |
| H1355 | 34% (89) | 0% | 100% (294) |
| SCC | |||
| SCC-Cher | 93% (93) | ND | 82% (27) |
| Ludlu | 92% (64) | 34% (19) | 100% (360) |
| SK-Mes | 2% | 53% (47) | 100% (105) |
| SCLC cell lines | |||
| DMS53 | 56% (37) | 46% (43) | 100% (540) |
| DMS454 | 96% (151) | 58% (25) | 95% (1198) |
Numbers in parentheses correspond to mean fluorescence intensities. ND, not done.
a
Percentages of positive cells are indicated.